Latest news
Andrea Necchi: Trastuzumab Deruxtecan for HER2-Positive Urothelial Cancer Now Available in Italy - OncodailyOncodaily · Sun, 09 Aug 2026 12:03:13 GMTAndrea Necchi: A Combined Analysis of PURE01 and SURE02 - OncodailyOncodaily · Tue, 04 Aug 2026 19:04:50 GMTAndrea Necchi: Our First Network Meta-Analysis of Perioperative Trials in MIBC - OncodailyOncodaily · Fri, 31 Jul 2026 07:00:00 GMT